Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited) - 3 months ended Mar. 31, 2017 - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Common Stock Issuable
Balance at Dec. 31, 2016	$ (911,682)	$ 6,575	$ 1,199,511	$ (2,124,219)	$ 6,451
Balance, Shares at Dec. 31, 2016		65,753,640
Sale of common stock	$ 210,000	$ 210	$ 209,790
Sale of common stock, Shares	2,100,000
Fair value of warrants allocated to proceeds of convertible notes payable	$ 7,506		7,506
Fair value of warrants issued pursuant to Amended Investment Agreement	56,635		56,635
Consultant fees payable with common shares	8,903				8,903
Shares and options issued pursuant to employee equity incentive plan	5,785		5,764		21
Net loss	(477,121)			(477,121)
Balance at Mar. 31, 2017	$ (1,099,974)	$ 6,785	$ 1,479,206	$ (2,601,340)	$ 15,375
Balance, Shares at Mar. 31, 2017		67,853,640